LAURIE WALSH: Open Payments
NPI 1023396272 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 40 payments from 20 companies in 2025. Trend: 2023 $1,154 · 2024 $611 · 2025 $900
Food & beverage: $845Education: $55
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 11 | $241 |
| Neurocrine BioSciences, Inc. | 3 | $87 |
| Inspire Medical Systems, Inc. | 4 | $84 |
| UCB, Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $47 |
| Biogen, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Amgen Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
Products named: WAKIX, INGREZZA, INSPIRE, VYALEV, TYSABRI, HYQVIA, EVENITY, REXULTI.
Industry payments across GA — which companies pay providers there.
